Last reviewed · How we verify
NCT06798402
Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate
Phase 2 trial testing Ciprofloxacin (BAYO9867) in Cutaneous Leishmaniasis in 80 participants. Currently enrolling.
1 November 2025
Quick facts
| Lead sponsor | Al-Mustafa University College |
|---|---|
| Phase | Phase 2 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 7 February 2025 |
| Primary completion | 1 November 2025 |
| Estimated completion | 1 November 2025 |
| Sites | 1 location across Iraq |
Drugs / interventions tested
- Ciprofloxacin (BAYO9867) — full drug profile →
- sodium stibogluconate (Pentostam) — full drug profile →
Conditions studied
- Cutaneous Leishmaniasis — all drugs for Cutaneous Leishmaniasis →
Sponsor
Al-Mustafa University College
Who can join
Adults 18 to 80, any sex, with Cutaneous Leishmaniasis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Aim of the trial to evaluate the effectiveness of intralesional ciprofloxacin 0.2% solution as a local injection in treating cutaneous leishmaniasis and compare its effect with intralesional sodium stibogluconate (SSG) 10% intravenous solution in cutaneous leishmaniasis as a local injection. In a randomized parallel groups clinical trial, patients were divided into two groups based on therapeutic regimen: 1) intralesional sodium stibogluconate weekly injection and 2) intralesional ciprofloxacin injection. Each lesion was considered a case in the final analysis. Each lesion will be followed up for 90 days (censor endpoint) or until the lesions are cured.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06798402
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cutaneous Leishmaniasis
Currently open trials in the same condition.
- NCT06798415 — Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis · Phase 2 · recruiting
- NCT06797544 — Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis · Phase 2 · recruiting
Other Al-Mustafa University College trials
Trials by the same sponsor.
- NCT06007430 — Colostrum Supplements Effect on the Physical Performance and Cognitive Function · Phase 2 · completed
- NCT06044987 — Effect of Cystocele Repair With Trans Obturator Tape VS. Trans Obturator Tape Alone on Stress Urinary Incontinence. · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06798402 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Al-Mustafa University College
- Last refreshed: 30 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06798402.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing